Oscar Health (NYSE:OSCR) Stock Price Up 6.7% – Still a Buy?

Oscar Health, Inc. (NYSE:OSCR)’s share price was up 6.7% during trading on Thursday . The stock traded as high as $14.32 and last traded at $14.30. Approximately 1,163,513 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 3,475,479 shares. The stock had previously closed at $13.40.

Analysts Set New Price Targets

OSCR has been the topic of several recent analyst reports. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Finally, Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Trading Up 5.7 %

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a fifty day simple moving average of $15.65 and a two-hundred day simple moving average of $17.28. The firm has a market capitalization of $3.50 billion, a P/E ratio of -236.13 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the company posted ($0.29) EPS. The firm’s revenue was up 68.3% compared to the same quarter last year. On average, equities research analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the transaction, the director now owns 89,512 shares of the company’s stock, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in OSCR. Point72 Hong Kong Ltd purchased a new position in Oscar Health during the second quarter worth about $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health during the 2nd quarter valued at about $93,000. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares in the last quarter. Amalgamated Bank increased its position in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Oscar Health in the third quarter worth approximately $142,000. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.